Beacon lights up with $170m for retinal disease gene therapy

Beacon lights up with $170m for retinal disease gene therapy

Submitted by admin on July 3, 2024 - 11:21am
Source: 
Pharmaphorum
News Tags: 
Beacon Therapeutics
funding
gene editing
X-linked retinitis pigmentosa
retinal diseases
Headline: 
Beacon lights up with $170m for retinal disease gene therapy
snippet: 

UK-headquartered Beacon Therapeutics has raised a whopping $170 million in second-round financing that will be used to advance a gene therapy for an inherited cause of blindness through a pivotal trial.

Do Not Allow Advertisers to Use My Personal information